Ceftriaxone-by-default in surgical prophylaxis across the East African community: a measurement problem
13 affiliations
- 1Human Health Department, One Health Antimicrobial Resistance Network (OHAAN), Nairobi, Kenya
- 2Medical Department, Wajir County Referral Hospital, Wajir, Kenya
- 3Department of Community Health, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda
- 4Surgical Department, Garissa County Referral Hospital, Garissa, Kenya
- 5Infectious Disease Department, National Institute of Health, Mogadishu, Somalia
- 6Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
- 7National Reference Laboratory, National Institute of Public Health, Bujumbura, Burundi
- 8Department of Environmental Health and Disease Control, School of Public Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
- 9Expanded Programme on Immunization (EPI), Ministry of Health, Juba, South Sudan
- 10Biomedical Laboratory Sciences Department, School of Health Sciences, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda
- 11Department of Microbiology and Parasitology, Faculty of Health Sciences, Mbarara University of Science and Technology, Mbarara, Uganda
- 12South African Medical Research Council–University of Venda Antimicrobial Resistance and Global Health Research Unit (SAMRC-UNIVEN) Antimicrobial Resistance and Global Health Research Unit, Institute for Pathogen and Global Health Research, University of Venda, Thohoyandou, South Africa
- 13Department of Science, Technology and Innovation (DSTI) / National Research Foundation (NRF) South African Research Chairs Initiative (SARChI), Institute for Pathogen and Global Health Research, University of Venda, Thohoyandou, South Africa
Abstract
Surgical antibiotic prophylaxis across the East African Community is dominated by ceftriaxone, a WHO Access, Watch, and Reserve (AWaRe) Watch-group third-generation cephalosporin not recommended for routine prophylaxis. The practice recurs across regional point prevalence surveys, yet consumption surveillance cannot distinguish prophylactic from therapeutic use. Drawing on antimicrobial-use surveys, surgical-prophylaxis studies, resistance surveillance, and medicine-availability reports, we argue that four interacting failure modes sustain it: substitution of first-line agents, prolongation of postoperative prophylaxis, unnecessary combination, and empirical spillover from ward prescribing. Resistance among surgical-site isolates is already high enough to threaten the value of prophylaxis itself. Prophylaxis is measured for duration, documented indication, and guideline concordance, and agent choice is captured in point-prevalence surveys, but none of this reaches the national consumption totals that govern procurement, and no indicator records the supply constraint determining the agent or the resistance it selects. We propose four measures, one requiring routing rather than building and three genuinely absent, that would convert an ungoverned practice into a governable one.
Related
- The vagus nerve drives cognitive function through the default mode network
- A Spiking Neural Network Model of Elementary Self-Consciousness via Endogenous Default Mode Network Dynamics
- The Accuracy Paradox: Empirical Diagnostic of Default Decision Thresholds in Multi-Label Enzyme Commission Prediction [With Code]
- Electroencephalographic activity patterns distinguish interdigitated default and frontoparietal networks
- Registered Reports as the default pathway for confirmatory publication
BibTeX
@article{abdullahi2026ceftriaxonebydefault,
title = {{Ceftriaxone-by-default in surgical prophylaxis across the East African community: a measurement problem}},
author = {Samar Rashid Abdullahi and Nathan Mugenyi and Lucy Ochola and Jamal Abade Mohamed and Hussein Iman Sigat and Abdirizak Ali Yusuf and Wigilya P. Mikomangwa and Armstrong Ndihokubwayo and David Majuch Kunjok and Schifra Uwamungu and Nathan Banzi and Barbra Tuhamize},
journal = {Frontiers in Antibiotics},
year = {2026},
month = oct,
doi = {10.3389/frabi.2026.1968363},
url = {https://doi.org/10.3389/frabi.2026.1968363},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Ceftriaxone-by-default in surgical prophylaxis across the East African community: a measurement problem
AU - Samar Rashid Abdullahi
AU - Nathan Mugenyi
AU - Lucy Ochola
AU - Jamal Abade Mohamed
AU - Hussein Iman Sigat
AU - Abdirizak Ali Yusuf
AU - Wigilya P. Mikomangwa
AU - Armstrong Ndihokubwayo
AU - David Majuch Kunjok
AU - Schifra Uwamungu
AU - Nathan Banzi
AU - Barbra Tuhamize
PY - 2026
DA - 2026/10/12
JO - Frontiers in Antibiotics
DO - 10.3389/frabi.2026.1968363
UR - https://doi.org/10.3389/frabi.2026.1968363
AB - Surgical antibiotic prophylaxis across the East African Community is dominated by ceftriaxone, a WHO Access, Watch, and Reserve (AWaRe) Watch-group third-generation cephalosporin not recommended for routine prophylaxis. The practice recurs across regional point prevalence surveys, yet consumption surveillance cannot distinguish prophylactic from therapeutic use. Drawing on antimicrobial-use surveys, surgical-prophylaxis studies, resistance surveillance, and medicine-availability reports, we argue that four interacting failure modes sustain it: substitution of first-line agents, prolongation of postoperative prophylaxis, unnecessary combination, and empirical spillover from ward prescribing. Resistance among surgical-site isolates is already high enough to threaten the value of prophylaxis itself. Prophylaxis is measured for duration, documented indication, and guideline concordance, and agent choice is captured in point-prevalence surveys, but none of this reaches the national consumption totals that govern procurement, and no indicator records the supply constraint determining the agent or the resistance it selects. We propose four measures, one requiring routing rather than building and three genuinely absent, that would convert an ungoverned practice into a governable one.
SN - 2813-2467
ER -